Search NEL Online

Comparative Study 2008; 29(2): 240-245 PubMed PMID: 18404145 Citation  Keywords:  Adult, Aged, CD4 Lymphocyte Count, CD4-Positive T-Lymphocytes:cytology, Case-Control Studies, Female, Flow Cytometry, Humans, Interleukin-2 Receptor alpha Subunit:metabolism, Male, Middle Aged, Neoplasms:blood, Phenotype, Prognosis, Survival Analysis, T-L.   

AIM: Regulatory T cells (Treg) that prevent autoimmune diseases by suppression of self-reactive T cells may also suppress the immune response against cancer. Experimental tumor models in mice revealed that Tregs are potent inhibitors of an antitumor immune response. The purpose of the study was to identify a CD4+ population of regulatory T cells expressing high levels of CD25(CD4+CD25 high) in the peripheral blood of cancer patients and provide the opportunity to determine whether cancer patients exhibit an expanded CD4+CD25high pool.

METHODS: The frequency of CD4+CD25high in the peripheral blood of 62 cancer patients and 15 healthy donors was determined by flow cytometry.

RESULTS: Compared with healthy donors, cancer patients have an increasing prevalence of CD4+CD25high T cells in the peripheral blood with characteristics of Tregs, i.e. they are CD45-RA(), CD69(-). Among patients, those with higher percentages of CD4+CD25high T cells had a poor prognosis than did those with lower percentages.

CONCLUSION: We provide evidence of an increased pool of CD4+CD25high in the peripheral blood of cancer patients, which may be related to immunosuppression and tumor progress in cancer patients. This finding suggests that the use of immunomodulatory therapy to treat cancer patients may be an effective strategy....

Read abstract  Full text PDF

Journal Article 2006; 27(6): 795-798 PubMed PMID: 17187004 Citation  Keywords:  Adult, Female, Glycoprotein Hormones, alpha Subunit:metabolism, Humans, Male, Middle Aged, Prolactin:metabolism, Reference Values, Stimulation, Chemical, Thyroid Function Tests, Thyrotropin:metabolism, Thyrotropin-Releasing Hormone:physiology,.   

OBJECTIVE: The alpha-subunit (Alpha-SU) response to TRH was studied to examine the response of alpha-SU under TRH stimulation in normal situation.

METHODS: Thirty seven healthy individuals were included in the study. They were divided into two groups according to the data taken: A with TSH equal or more than seven fold the basal values (0: 3.14+/-1.2 microU/ml., 30 after TRH: 20.22+/-4.6 microU/ml) and B with TSH 2 to 6 fold the basal values (0: 0.5+/-0.1 microU/ml., 30 after TRH: 2.9+/-0.5 microU/ml). Both groups exhibited similar FT3 and FT4 levels.

RESULTS: In group A, prolactin displayed a 3 fold increase from the basal values, whereas alpha-SU increased 4 fold with a difference being statistically significant (p<0.001). In contrast, in group B individuals neither prolactin nor alpha-SU exhibited any significant difference from the basal values.

CONCLUSION: The expression of alpha-SU upon TRH stimulation is dependent on the TSH basal values....

Read abstract  Full text PDF